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IMPORTANCE Depression often first manifests in adolescence. Thereafter, individual
trajectories vary substantially, but it is not knownwhat shapes depression trajectories in
youth. Adult studies suggest that genetic risk for schizophrenia, a psychiatric disorder with a
neurodevelopmental component, may contribute to an earlier onset of depression.
OBJECTIVE To test the hypothesis that there are distinct trajectories of depressive symptoms
and that genetic liability for neurodevelopmental psychiatric disorders (eg, schizophrenia,
attention deficit/hyperactivity disorder [ADHD]), as well as for major depressive disorder
(MDD), contribute to early-onset depression.
DESIGN, SETTING, AND PARTICIPANTS The Avon Longitudinal Study of Parents and Children is
an ongoing, prospective, longitudinal, population-based cohort that has been collecting data
since September 6, 1990, including data on 7543 adolescents with depressive symptoms at
multiple time points. The present study was conducted between November 10, 2017, and
August 14, 2018.
MAIN OUTCOMES ANDMEASURES Trajectories based on self-reported depressive symptoms
dichotomized by the clinical cutpoint; MDD, schizophrenia, and ADHD polygenic risk score
(PRS) were predictors.
RESULTS In 7543 adolescentswith depression data onmore than 1 assessment point between a
mean (SD) age of 10.64 (0.25) years and 18.65 (0.49) years (3568 [47.3%]male; 3975 [52.7%]
female), 3 trajectory classeswere identified: persistently low (73.7%), later-adolescence onset
(17.3%), and early-adolescence onset (9.0%). The later-adolescence–onset classwas associated
withMDDgenetic risk only (MDDPRS: odds ratio [OR], 1.27; 95%CI, 1.09-1.48; P = .003). The
early-adolescence–onset classwas also associatedwithMDDgenetic risk (MDDPRS:OR, 1.24;
95%CI, 1.06-1.46; P = .007) but additionallywith genetic risk for neurodevelopmental disorders
(schizophrenia PRS: OR, 1.22; 95%CI, 1.04-1.43; P = .01; ADHDPRS:OR, 1.32; 95%CI, 1.13-1.54;
P < .001) and childhoodADHD (χ21 = 6.837; P = .009) and neurodevelopmental traits (pragmatic
language difficulties: OR, 1.31; P = .004; social communication difficulties: OR, 0.68; P < .001).
CONCLUSIONS AND RELEVANCE The findings of this study appear to demonstrate evidence of
distinct depressive trajectories, primarily distinguished by age at onset. Themore typical
depression trajectory with onset of clinically significant symptoms at age 16 years was
associated with MDD genetic risk. The less-common depression trajectory, with a very early
onset, was particularly associated with ADHD and schizophrenia genetic risk and,
phenotypically, with childhood ADHD and neurodevelopmental traits. Findings are consistent
with emerging evidence for a neurodevelopmental component in some cases of depression
and suggest that the presence of this component may bemore likely when the onset of
depression is very early.
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M ajor depressive disorder (MDD) is themost commonmentaldisorderandaleadingcauseofdisability1;evensubthreshold depressive symptoms are associated
with functional impairment and future mental health
problems.2,3Depressionoften firstmanifests inadolescence4-6
and, thereafter, individual trajectories of depressive symp-
tomsvary substantially.7A familyhistoryofdepressionandan
earlyageatonsetareeachassociatedwithamorechronicsymp-
tom course in adults with MDD,8-10 but it is not known what
shapes early depression trajectories in youth.
Depressionhas a complexmultifactorial set of causes, in-
cluding a moderate heritable component.4,11,12 Longitudinal
and family studies showcontinuitybetweenbothadolescence-
onset depressive disorder and symptoms with depression in
adult life, but there are also developmental differences be-
tweendepression in children, adolescents, andadults.4For in-
stance, clinical follow-up studies of very early-onset depres-
sion (average age at onset, 10.7 years) report high rates of
heterotypic continuity,wheredepression is often followedby
adifferent typeof clinical disorder.13-15 Twin studies also show
differences in the genetic set of causes of very early-onset de-
pressive symptomscomparedwith thosearising inmid- to late
adolescence.16-18
At the molecular level, a recent genome-wide association
study of adults withMDD found evidence of differences in the
genetic architecture of depression where a relatively early age
at onset (before themedian age at onset of 27 years) was asso-
ciatedwithgenetic liability toschizophrenia, anassociationnot
seen for later-onset depression, which was instead associated
withMDDrisk alleles.19 Similar findingshavebeen reported for
emotional problems (symptoms of depression and anxiety) in
that emotional problems in childhood were associated with
schizophrenia risk alleles, but in adult life they were addition-
ally associated with MDD genetic risk.20 The association of
schizophrenia risk alleles with childhood emotional problems
was particularly pronounced in those with emotional prob-
lems in both childhood and adulthood, suggesting that per-
sistent emotional symptomsbeginning earlymaydrive the as-
sociation with schizophrenia risk alleles. As schizophrenia
genetic risk is thought to involve an early neurodevelopmen-
tal component,21,22 the role of genetic risk for other neurode-
velopmental disorders in early-onset depression may be im-
portant to consider. In particular, genetic risk for ADHD, a
common childhood-onset neurodevelopmental disorder,may
be important in early-onset depression because cross-
sectionalandlongitudinalcohortstudiesshowheightenedrates
of depression in childrenwithADHD,23-25whichmaybepartly
due to the strong genetic correlation between ADHD and de-
pression (rg = 0.424).26,27
Herein, we test the contribution of neuropsychiatric dis-
order genetic risk variants, specifically genetic liability to
MDD, schizophrenia, andADHD, to early depression trajecto-
ries. Schizophrenia and ADHD were selected in addition to
MDDas they showmoderate to high genetic correlationswith
major depression,27 there is evidence linking schizophrenia
polygenic risk score (PRS) to early-onset depression,19,20 and
epidemiologic and clinical evidence15,23-25 that ADHDmay be
an important antecedent of depression.
Estimates of genetic liability to thedisorders in the formof
PRSswerederived fromrisk alleles defined in the largest avail-
able genome-wide association studyof thosedisorders.26,28,29
We did not have a specific hypothesis for bipolar disorder ge-
netic risk because existing studies reporting conflicting results
about thephenotypic associationbetweenearly-onsetdepres-
sionandbipolardisorder,13,15,30with littleevidence that thisas-
sociation is stronger for early-onset depression. Bipolar disor-
der alsodiffers fromADHDandschizophrenia in that evidence
suggests that bipolar disorder is less neurodevelopmental in
origin.21,22However, forcompleteness,weincludedbipolarPRSs
in our analyses (eTable 2A in the Supplement). We hypoth-
esized that ADHD and schizophrenia genetic risk would show
an association with early-onset depression and that depres-
sion genetic risk would be associated with depression with an
onset later in adolescence.
Methods
TheAvonLongitudinalStudyofParentsandChildren (ALSPAC)
is an ongoing, population-based, prospective, longitudinal UK
birth cohort.31,32 Data collection began September 6, 1990. The
enrolledcoresampleconsistedof 14541pregnantwomenliving
inAvon,England,withexpecteddeliverydatesbetweenApril 1,
1991,andDecember31,1992.Ofthesebirths,13988childrenwere
alive at 1 year. An additional 713 childrenwhowouldhave been
eligiblebutwhosemothersdidnotchoose toparticipateduring
pregnancywereenrolledafter age7years, givinga total sample
of14701childrenaliveat1year.Thepresentstudywasconducted
betweenNovember 10, 2017, andAugust 14, 2018.
EthicalapprovalforthestudywasobtainedfromtheALSPAC
EthicsandLawCommitteeandthelocal researchethicscommit-
tees. All participants providedwritten informed consent; there
was no financial compensation.
The studywebsite containsdetails of all of thedata that are
available througha fully searchabledatadictionary.33 For fami-
lies with multiple births, we included the oldest sibling. Indi-
vidualswere includedinanalyseswhendataontheprimaryout-
comeof depressive symptomswere available for at least 2 time
Key Points
Question Do neuropsychiatric disorder genetic risk variants
influence developmental trajectories of depression in youth?
Findings In this population-based study including 7543
adolescents, distinct depression trajectory classes were identified.
A later-adolescence–onset class (17.3% of the sample) showed a
typical depression trajectory and was associated with major
depressive disorder risk alleles, and an early-adolescence–onset
class (9.0%) showed clinically significant symptoms at age 12 years
and was associated with schizophrenia and attention-deficit
hyperactivity disorder genetic risk, childhood attention-deficit
hyperactivity disorder, and neurodevelopmental traits.
Meaning Depression in youth is heterogeneous; findings are
consistent with emerging evidence for a neurodevelopmental
component to some cases of depression and that this component
is more likely when onset is very early.
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points (n = 7543). The sample mean age (SD) was 10.64 (0.25)
years at baseline and 18.65 (0.49) years at the final time point.
Thenumbersof individualswithdataavailableatdifferenttimes
are shown in the eFigure in the Supplement.
Depressive symptoms were reported by the young per-
son at 6 time points (ages 10.5, 12.5, 13.5, 16.5, 17.5, and 18.5
years) on the short Mood and Feelings Questionnaire. This is
a well-validated symptom checklist34-36 that includes 13
items about mood symptoms during the past 2 weeks (rated
0, not true; 1, sometimes true; or 2, true; score range, 0-26).
Scores above 11 represent clinically significant symptoms,34,36
and we analyzed individuals scoring above and below this
level to examine trajectories of clinically significant
symptoms.
Polygenic risk scores for MDD, schizophrenia, and ADHD
weregenerated in study individuals as the standardizedmean
number of disorder risk alleles in approximate linkage equi-
librium(R2<0.20),weightedbygenome-wideassociationstudy
allele effect size derived from data of imputed autosomal
single-nucleotide polymorphisms. All analyses were per-
formedusing Stata, version 13.0 (StataCorp) to implement the
PLINK toolset (http://zzz.bwh.harvard.edu/plink/; code is
available at https://github.com/ricanney/stata). In brief, best-
guess genotype underwent additional marker and individual
quality control. Individuals were excluded on the basis of
excessive heterozygosity (>4 SDs from sample mean),
relatedness (>3 SDs from sample mean), and genotype
missingness (>2%). Markers were excluded if they were rare
(minor allele count <5), had high levels ofmissingness (>2%),
or deviated from Hardy-Weinberg equilibrium (P ≤ 10−10) or
fromreferenceminorallele frequency (>10%) (eMethods in the
Supplement).
Scores were derived from MDD, ADHD, and schizophre-
niaweights for 152 536, 103041, and 27 336 single-nucleotide
polymorphisms, respectively.Riskallelesweredefinedas those
associatedwith case status in themost recent Psychiatric Ge-
nomicsConsortiumanalyses ofMDD,ADHD, and schizophre-
nia at a threshold of P < .50 for depression and ADHD and
P < .05 for schizophrenia, as these thresholdsmaximally cap-
ture phenotypic variance.26-29,37 Genome-wide association
studydiscovery sample sizeswere 130664 cases and 330470
controls for MDD, 20 183 cases and 35 191 controls for ADHD,
and35476casesand46839controls forschizophrenia.AllPRSs
were standardized prior to analysis so odds ratios (ORs) rep-
resent 1 SD change (eTable 2A in the Supplement for bipolar
PRSs). Phenotypic measures of neurodevelopmental prob-
lems (DSM-IV38 diagnoses of childhood ADHD, social com-
munication problems, and pragmatic language difficulties
at age 7 years), psychotic experiences (ages 12 and 17 years),
family history of severe depression and schizophrenia, and
maternal educational level were used (eMethods in the
Supplement).
Statistical Analysis
Wecharacterizeddepression trajectoriesof symptomsdichoto-
mizedby clinical cutpoint (n = 7543) using latent class growth
analysis in Mplus, version 8.39 This analysis is a probability-
based technique used to identify an optimumnumber of dis-
tinct patterns (classes) of growth (change) in the longitudinal
depression scores of individuals.40 Models were run with in-
creasing numbers of classes, starting with a 1-class solution
specifying both linear and quadratic change with 500 ran-
dom starting values and 50 optimizations. Residual vari-
anceswereallowedtovaryacrossmeasurementpoints.Amaxi-
mum likelihoodparameter estimator forwhich SEs are robust
to nonnormality was used.
To examine associations with categorical variables
(eg, sex), theDCATauxiliary option inMPluswasused.Abias-
free, 3-step approach in MPlus (R3STEP) estimated the asso-
ciations between continuous hypothesized predictor
variables (PRSs) and trajectory class.41-43 Model selection
was informed by model fit indices and interpretability as
recommended.44 Full information maximum likelihood
estimation was used in MPlus and included all individuals
withmore than 1 depression assessment in analyses (eTable 1
in the Supplement). For tests of PRS association with trajec-
tory class, we reran analyses using inverse probability
weighting45 to address any potential bias caused by partici-
pant dropout. The pattern of results was similar (eTable 3 in
the Supplement).
Figure. Developmental Trajectories of Depressive Symptoms
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Results
Depression Symptom Trajectories
A 3-class trajectorymodel provided the best fit to the data and
results that were most readily interpretable (eTable 1 and
eAppendix1 intheSupplement).TheFigureshowsthe3distinct
trajectory classes: a persistently low class (73.7%), a later-
adolescence–onsetclass(17.3%),andanearly-adolescence–onset
class (9.0%). In theearly-adolescence–onsetclass, theprobabil-
ityofclinically significantdepressionwas firstelevated (as indi-
catedbyaprobabilityof clinically significantdepression symp-
tomsof0.44)atage12.5years,whichroseto0.52at13.5years. In
thelater-adolescence–onsetclass, theprobabilityofclinicallysig-
nificantdepression(probability,0.47)wasfirstelevatedatage16.5
yearsandroseat 17.5years (probability,0.57).Bothelevatedtra-
jectorieswere associatedwith a diagnosis ofMDD (assessed by
theClinical InterviewSchedule–Revised46atage17.5years)pro-
vidingvalidationof the trajectoryclasses (later-adolescenceon-
set,34.4%;early-adolescenceonset,22.8%;lowlevel, 1.5%;over-
all difference, χ22 = 193.70; P = .001). The estimated proportion
of femaleswas45.8% in the low-level class andwashigher, but
did not differ significantly, between the early-adolescence–
(74.3%) and later-adolescence– (73.2%) onset classes (Table 1).
Neuropsychiatric PRS and Trajectory Class
As reported in Table 2, the later-adolescence–onset class was
associated only with higher MDD PRS (OR, 1.27; 95% CI, 1.09-
1.48; P = .003). The early-adolescence–onset class was associ-
ated with higher PRSs for ADHD (OR, 1.32; 95% CI, 1.13-1.54;
P < .001), schizophrenia (OR, 1.22; 95% CI, 1.04-1.43; P = .01),
andMDD (OR, 1.24; 95% CI, 1.06-1.46; P = .007). Post hoc, we
examined the association with all 3 psychiatric PRSs and tra-
jectory class to examine which PRS contributed most
strongly (Table 2). As expected, the PRSs were correlated
(eTable 2B and C in the Supplement).
Multivariate analysis showed that the strongest associa-
tionwith the early-adolescence–onset class was observed for
ADHD PRS, the association with schizophrenia PRS was re-
tained, and the associationwithMDDPRSbecamenonsignifi-
cant (Table2).Results for the later-adolescence–onset class re-
mained the same.Comparing theearly- and later-onset classes
showed significant differences (MDD PRS: OR, 1.13; 95% CI,
0.88-1.46;P = .33; schizophrenia PRS:OR,0.78; 95%CI, 0.60-
Table 1. Phenotypic AssociationsWith Trajectory Classa
Variable
Onset, OR (95% CI)
Difference Between Early- and
Later-Adolescence–Onset Classesb
Early Adolescence P Value Later Adolescence P Value
χ21 or OR (95%
CI) P Value
Sex, % 74.3 <.001 73.2 <.001 χ 21 = 0.015 .90
Maternal education,
completed A-levels, %c
39.1 .01 34.9 .001 χ 21 = 0.707 .44
Childhood ADHD, % 6.3 .008 0.9 .37 χ 21 = 6.837 .009
Pragmatic language
difficultiesd
0.63 (0.55-0.71) <.001 0.82 (0.72-0.94) .006 OR, 1.31 .004
χ 21 = 11.709 .001 (for Cutpoint)
Social communication
difficultiese
1.50 (1.34-1.68) <.001 1.01 (0.87-1.18) .86 OR, 0.68 <.001
χ 21 = 18.819 .001 (for Cutpoint)
Psychotic experiences
12 y 1.47 (1.35-1.61) <.001 0.89 (0.64-1.22) .46 OR, 0.60 .003
17 y 1.57 (1.36-1.80) <.001 1.54 (1.33-1.79) <.001 OR, 0.99 .74
Abbreviations: ADHD, attention deficit/hyperactivity disorder; OR, odds ratio.
a Continuous scores are standardized so that ORs are for 1-SD increase. Low-risk
group was the reference group except for tests of comparison between
early-adolescence– and later-adolescence–onset groups where the
early-adolescence–onset group was the reference group.
b χ2 Tests of difference for social communication and pragmatic language
difficulties used the established clinical cut-points for identifying problems
(eAppendix in the Supplement). The OR values represent the difference
between the ORs in the preceding columns for later-adolescence onset vs
early-adolescence onset.
c A-level education is equivalent to high school diploma in the United States
d Lower scores represent more difficulties.
e Higher scores represent more problems.
Table 2. Associations of Polygenic Risk ScoresWith Trajectory Classes
Association
Onset, OR (95% CI)
Early Adolescence P Value Later Adolescence P Value
Univariate
MDD PRS 1.24 (1.06-1.46) .007 1.27 (1.09-1.48) .003
Schizophrenia PRS 1.22 (1.04-1.43) .01 .95 (0.82-1.11) .56
ADHD PRS 1.32 (1.13-1.54) <.001 .94 (0.80-1.11) .48
Multivariate
MDD PRS 1.16 (0.98-1.36) .09 1.31 (1.12-1.53) .001
Schizophrenia PRS 1.19 (1.01-1.41) .04 .93 (0.79-1.10) .39
ADHD PRS 1.27 (1.08-1.50) .003 .90 (0.76-1.07) .23
Abbreviations: ADHD, attention
deficit/hyperactivity disorder; MDD,
major depressive disorder; OR, odds
ratio; PRS, polygenic risk score.
Developmental Trajectories and Neuropsychiatric Genetic Risk Variants in Early-Onset Depression Original Investigation Research
jamapsychiatry.com (Reprinted) JAMAPsychiatry March 2019 Volume 76, Number 3 309
Downloaded From: https://jamanetwork.com/ by a Cardiff University User  on 03/14/2019
1.01; P = .08; and ADHD PRS: OR, 0.71; 95% CI, 0.55-0.92;
P = .009). Bipolar PRS was not associated with trajectory
classes (eTable 2A in the Supplement). Including ancestry-
derived principal components did not alter the results (eAp-
pendix 2 in the Supplement).
We tested whether the trajectory classes differed phe-
notypically on traits conceptually related to ADHD PRS
(childhoodADHDandneurodevelopmental traits) and schizo-
phrenia PRS (psychotic experiences). For childhood neuro-
developmental traits, there is evidence that these traits are
associatedwith bothADHDandADHDPRS47,48; for psychotic
experiences, there is inconsistent evidence that these experi-
ences are linked with psychosis and schizophrenia PRSs49,50
(Table 1). Individuals in the early-adolescence–onset class
had higher rates of childhood ADHD (6.3%) than the later-
adolescence–onset (0.9%) and low (1.7%) classes andmore so-
cial communicationandpragmatic languageproblems(Table1).
Proportions scoring above the standard cut points were early
onset, 20.7%; later onset, 4.2%; and low level, 5.8% for social
communicationandearlyonset,13.3%;lateronset,2.1%;andlow
level, 1.4% for pragmatic language. These differences distin-
guished the early-adolescence– and later-adolescence–onset
classes(Table2).Forpsychoticexperiences,thesedifferencesdis-
tinguishedtheearly-adolescence–and later-adolescence–onset
classes only at age 12 years.
Discussion
This study identified variation in thedevelopmental trajecto-
riesofdepression fromchildhood toearly adult life, andmore-
over, that this variation is partly attributable to MDD, schizo-
phrenia, andADHD risk alleles.We foundevidence of distinct
depressive trajectories primarily distinguished by age at on-
set.We found that themore common, typical developmental
trajectory,with onset after puberty andpersistence into early
adulthood,6,51wasassociatedwithelevatedgenetic risk forde-
pression indexed byMDD PRS. In contrast, we found that de-
pressive symptoms defined by a very early onset (by age 12
years) were associated with all neuropsychiatric genetic risk
scores assessed, with multivariate analysis showing that the
association was strongest for ADHD PRS.
Phenotypically, childhood neurodevelopmental difficul-
ties (ADHD,pragmatic language,andsocial communicationdif-
ficulties) differentiated the depression trajectories that were
elevatedonly in the early-adolescence–onset groupwith rates
increasedby5- to 7-fold in theearly-adolescence–onset group.
Psychotic experiences differentiated the groups only at age 12
years. This discrepancy may be driven by depressive symp-
tom differences between the groups at age 12 years (Figure)
given the reported association between psychotic experi-
encesanddepressionandan inconsistentassociationwithpsy-
chotic experiences and schizophrenia PRS.49,50 The findings
are consistent with a growing body of literature showing that
depressionhasheterogeneous causespartly indexedbyage at
onset. Inparticular, studies of adultMDDandsymptomsmea-
suredcontinuously inpopulation-basedsamples illustrate that
a relatively earlier onset is more strongly associated with
schizophrenia polygenic risk.19,20,52 We found an additional
contribution from ADHD PRSs.
The implication of those results is that early- and later-
adolescence-onset depression differ to some extent with re-
spect to the risk factors involvedand that theearlier-onsetdis-
order is more strongly influenced by neurodevelopmental
factors thandepressionwith amore typical onset in later ado-
lescence or early adulthood. This finding is consistent with a
numberof observations fromepidemiologic, family, andclini-
cal studies. First, several family and clinical follow-up stud-
ies suggest that childhood-onset depressionmight differ etio-
logically from adolescent-onset depression.53-56 Second, the
epidemiologic factors associated with very early-onset de-
pression differ from those of depression with onset in mida-
dolescence to late adolescence in the sex ratio of affected
individuals and long-term psychiatric outcomes.13,57 Third,
neurodevelopmentaldifficulties, including speechabnormali-
tiesandpoormotorskills, areparticularlyassociatedwithearly-
onset rather thanadolescent- or adult-onsetdepression.15,58,59
Fourth, substantial clinical evidence shows that children
with ADHD, a common neurodevelopmental disorder, are at
elevated risk of subsequent depressive symptoms, suicide at-
tempt, and emotional problems in adult life.25,60-63
Theory suggests neurodevelopmental difficulties as one
route to emotional disturbance through the repeated experi-
enceof academic failure andpeer rejection,64 althoughADHD
anddepressionmay also be associated owing to common risk
factors.65 A clinical issue is that the response to antidepres-
sant medication66-69 in youth is not as good as it is in adults
and evidence suggests the response to tricyclic antidepres-
santsmaydiffer inprepubertalvspostpubertaldepression.One
possibility is thatmoreneurodevelopmentaldepressionshows
a different type of treatment response.
Thepresent study indicates that genetic risk forADHDand
schizophrenia inthegeneralpopulation isassociatedwithaper-
sistent, early-onset trajectoryofdepressivesymptoms.Suchef-
fects couldoperate throughoverlappingbiologicalpathwaysas
well as evocative gene-environment correlationwhere genetic
factors influence traits that then affect environmental expo-
sures (eg, social exclusion) associated with depression. Irrita-
bility,which is common in childrenwithADHDandother neu-
rodevelopmentaldisorders, is indexedbygenetic risk forADHD
in youth70 and has been shown to increase risk for later
depression,71,72maybe a potential route throughwhichADHD
genetic risk increases the likelihood ofmood problems.
Amongthosewithearly-onsetdepression,wedidnot iden-
tify the equal sex ratio of affectedmales and females that has
often been reported when depression onset is very early.4,73
This findingwas somewhat surprising, andseveral factorsmay
have contributed to it. First, some research suggests that de-
pression is particularly likely in females with neurodevelop-
mental disorders, which may imply that high neurodevelop-
mental risk is more likely to manifest as mood disorder in
females.24,48,74 Second,while it is generally accepted that self-
reports of adolescentmood (as used in the present study) are
reliable, children with neurodevelopmental disorders, pre-
dominately boys, may underreport their mood symptoms
compared with typically developing children.75 This report-
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ing difference raises the possibility that the reliance on self-
reported mood necessary in the present study due to re-
peated longitudinal assessments (see below) may mean that
some individuals at high neurodevelopmental risk may
have beenmisclassified. Finally, PRSs alone are unlikely to be
able to reliably classify children’s risk of developing different
types of depression trajectories. However, collectively, re-
sults converge to suggest that neurodevelopmental pheno-
types (ADHD, aswell as social communication and pragmatic
language difficulties) and neurodevelopmental genetic risk
indicate a greater probability of an early-onset depression tra-
jectory. Phenotypic childhood neurodevelopmental prob-
lems were markedly increased in the early-adolescence–
onset group (by 5- to 7-fold) compared with the typical
depression trajectory. Studieswith follow-up further intoadult
life will help to clarify the adult mental health outcomes of
these groups.
Strengths and Limitations
Strengths of this study include the repeated-measures longi-
tudinal designwheredepressionwas assessedusing the same
measure and informant. Typically, longitudinal studies in-
clude changes in measurement and informant, in particular,
as children age, the informant tends to change from the par-
ent to the young person. This variation provides a challenge
to studies seeking to examine the development of symptoms
over timebecausechangesofmeasurementand informant can
affect results. This invariance of measurement over time is a
strength.
One limitation of our investigation is that, likemany lon-
gitudinal studies, nonrandomattritionoccurs inALSPACover
time (eAppendix 2 in the Supplement). This nonrandom loss
of participants is likely to result in conservative estimates of
the prevalence of the elevated depression trajectory groups.
We used a number of approaches to deal with missing data,
including full information maximum likelihood in trajectory
modeling and inverse probability weighting for tests of asso-
ciation. The pattern of results was replicated using inverse
probabilityweighting.Nonetheless, themissingdata assump-
tionmade in our analyses is that there are not systematic dif-
ferences betweenparticipantswhodoanddonot provide tra-
jectorydata andmembership in the sample after conditioning
on the other variables in the model (eg, PRS and variables
included in the inverse probability weighting analysis).
Depression was assessed using self-reported question-
naires rather thanclinical assessment.Nonetheless, subthresh-
old symptoms are associated with impairment and subse-
quentMDD.2-4 Itwasnotpossible to investigate rates ofmania
or bipolar disorder in the trajectory groups. However, evi-
dence is inconsistent on the link with early-onset depression
andbipolar disorder.13,15,30 The follow-upperiod in this study
was limited to early adult life. A final limitation is that PRSs
are weak predictors and explain only a small to modest pro-
portion of phenotypic variance as they do in the present
article. However, they provide a useful biological indicator of
genetic liability.76
Conclusions
The findings of this study suggest etiologically distinct trajec-
tories of depressive symptoms in youth dependent on age at
onset. The findings also show that neurodevelopmental ge-
netic risk contributes to very early-onset depression.
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